Combined hepatitis A and B vaccine (Sinovac Biotech)

甲型乙型肝炎联合疫苗 （科兴生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCombined hepatitis A and B vaccine (Sinovac Biotech)
Drug Alias NameHepatitis A - hepatitis B vaccine - Sinovac BiotechBilive倍尔来福
ClassificationVaccines > Application > Therapeutic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Vaccine type > Combination vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis AHepatitis B
Global Approved IndicationsHepatitis AHepatitis B
Approved Indications in ChinaHepatitis AHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date2005/01/07
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSinovac Biotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Biotech Ltd
Inactive CompaniesSinovac Biotech Co Ltd
Active IndicationsHepatitis AHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ07BC
Related LinksN/A